164 related articles for article (PubMed ID: 38766816)
1. Involvement of S100A6/S100A11 in T-Cell Immune Regulatory in HCC Revealed by Single Cell RNA-seq.
Zhou R; Pei B; Li X; Zhang X
Technol Cancer Res Treat; 2024; 23():15330338241252610. PubMed ID: 38766816
[No Abstract] [Full Text] [Related]
2. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment.
Ma LN; Ma Y; Luo X; Ma ZM; Ma LN; Ding XC
Sci Rep; 2024 May; 14(1):12149. PubMed ID: 38802416
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive scRNA-seq Analysis and Identification of CD8_+T Cell Related Gene Markers for Predicting Prognosis and Drug Resistance of Hepatocellular Carcinoma.
Cao L; Liu M; Ma X; Rong P; Zhang J; Wang W
Curr Med Chem; 2024; 31(17):2414-2430. PubMed ID: 37936457
[TBL] [Abstract][Full Text] [Related]
4. Involvement of NF-kappaB in the regulation of S100A6 gene expression in human hepatoblastoma cell line HepG2.
Joo JH; Kim JW; Lee Y; Yoon SY; Kim JH; Paik SG; Choe IS
Biochem Biophys Res Commun; 2003 Jul; 307(2):274-80. PubMed ID: 12859951
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma.
Li Z; Tang M; Ling B; Liu S; Zheng Y; Nie C; Yuan Z; Zhou L; Guo G; Tong A; Wei Y
J Mol Med (Berl); 2014 Mar; 92(3):291-303. PubMed ID: 24281831
[TBL] [Abstract][Full Text] [Related]
6. Constructing immune and prognostic features associated with ADCP in hepatocellular carcinoma and pan-cancer based on scRNA-seq and bulk RNA-seq.
Zhang Z; Li Y; Quan Z; Li Y; Zhu L; Sun S; Chen X
Front Immunol; 2024; 15():1397541. PubMed ID: 38774870
[TBL] [Abstract][Full Text] [Related]
7. EGFRvIII mediates hepatocellular carcinoma cell invasion by promoting S100 calcium binding protein A11 expression.
Luo X; Xie H; Long X; Zhou M; Xu Z; Shi B; Jiang H; Li Z
PLoS One; 2013; 8(12):e83332. PubMed ID: 24376686
[TBL] [Abstract][Full Text] [Related]
8. CD74
Xiao N; Li K; Zhu X; Xu B; Liu X; Lei M; Sun HC
Cancer Immunol Immunother; 2022 Jan; 71(1):57-69. PubMed ID: 34009409
[TBL] [Abstract][Full Text] [Related]
9. Tissue mRNA for S100A4, S100A6, S100A8, S100A9, S100A11 and S100P Proteins in Colorectal Neoplasia: A Pilot Study.
Peterova E; Bures J; Moravkova P; Kohoutova D
Molecules; 2021 Jan; 26(2):. PubMed ID: 33466593
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
[TBL] [Abstract][Full Text] [Related]
11. PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma.
Wang N; Tan HY; Lu Y; Chan YT; Wang D; Guo W; Xu Y; Zhang C; Chen F; Tang G; Feng Y
Signal Transduct Target Ther; 2021 Feb; 6(1):86. PubMed ID: 33633112
[TBL] [Abstract][Full Text] [Related]
12. Colon-derived liver metastasis, colorectal carcinoma, and hepatocellular carcinoma can be discriminated by the Ca(2+)-binding proteins S100A6 and S100A11.
Melle C; Ernst G; Schimmel B; Bleul A; von Eggeling F
PLoS One; 2008; 3(12):e3767. PubMed ID: 19048101
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of the Prognosis and Correlations With Immune Infiltration of S100 Protein Family Members in Hepatocellular Carcinoma.
Zheng S; Liu L; Xue T; Jing C; Xu X; Wu Y; Wang M; Xie X; Zhang B
Front Genet; 2021; 12():648156. PubMed ID: 33815482
[TBL] [Abstract][Full Text] [Related]
14. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
15. S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway.
Chen T; Ruan Y; Ji L; Cai J; Tong M; Xue Y; Zhao H; Cai X; Xu J
Cancer Lett; 2024 Apr; 587():216709. PubMed ID: 38350547
[TBL] [Abstract][Full Text] [Related]
16. Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.
Ouyang G; Li Q; Wei Y; Dai W; Deng H; Liu Y; Li J; Li M; Luo S; Li S; Liang Y; Pan G; Yang J; Gan T
Front Immunol; 2024; 15():1323199. PubMed ID: 38742112
[TBL] [Abstract][Full Text] [Related]
17. TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.
Jiang Y; Chen S; Li Q; Liang J; Lin W; Li J; Liu Z; Wen M; Cao M; Hong J
Front Immunol; 2021; 12():612139. PubMed ID: 33679751
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
Mo Z; Liu D; Rong D; Zhang S
Front Immunol; 2021; 12():611058. PubMed ID: 33679749
[No Abstract] [Full Text] [Related]
19. Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA.
Wang C; Chen C; Hu W; Tao L; Chen J
Apoptosis; 2024 Apr; 29(3-4):460-481. PubMed ID: 38017206
[TBL] [Abstract][Full Text] [Related]
20. Single-cell profiling reveals the metastasis-associated immune signature of hepatocellular carcinoma.
Zhong D; Shi Y; Ma W; Liang Y; Liu H; Qin Y; Zhang L; Yang Q; Huang X; Lu Y; Shang J
Immun Inflamm Dis; 2024 May; 12(5):e1264. PubMed ID: 38780041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
